يعرض 1 - 6 نتائج من 6 نتيجة بحث عن '"Lauri Urvas"', وقت الاستعلام: 1.01s تنقيح النتائج
  1. 1
  2. 2

    المساهمون: Divisions of Faculty of Pharmacy, Division of Pharmaceutical Chemistry and Technology, Drug Research Program, Pharmaceutical Design and Discovery group, Veterinary Biosciences, Faculty of Veterinary Medicine, Faculty of Pharmacy, Department of Pharmacology, Jari Yli-Kauhaluoma / Principal Investigator, Computational Adme, Henri Xhaard / Principal Investigator, Division of Pharmaceutical Biosciences, Erik Wallen / Principal Investigator

    وصف الملف: application/pdf; fulltext

  3. 3

    المساهمون: University of Helsinki, Åbo Akademi University, Department of Chemistry and Materials Science, Aalto-yliopisto, Aalto University, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, Divisions of Faculty of Pharmacy, Department of Chemistry, Susanne Wiedmer / Principal Investigator, Tiina Sikanen / Chemical Microsystems Lab

    المصدر: Analytical and Bioanalytical Chemistry

    وصف الملف: application/pdf

  4. 4

    المساهمون: Regenerative pharmacology group, PREP in neurodegenerative disorders, Division of Pharmacology and Pharmacotherapy, Drug Research Program, Divisions of Faculty of Pharmacy, University of Helsinki, Faculty of Pharmacy, University Management

    المصدر: Svarcbahs, R, Jäntti, M, Kilpeläinen, T, Julku, U H, Urvas, L, Kivioja, S, Norrbacka, S & Myöhänen, T T 2020, ' Prolyl oligopeptidase inhibition activates autophagy via protein phosphatase 2A ', Pharmacological Research, vol. 151, 104558, pp. 104558 . https://doi.org/10.1016/j.phrs.2019.104558

    مصطلحات موضوعية: 0301 basic medicine, Male, ALPHA-SYNUCLEIN, MODULATING AUTOPHAGY, Parkinson's disease, Oligopeptidase, Inbred C57BL, DISEASE, 107970) [FTY-720 (fingolimod, PubChem CID], Mice, 0302 clinical medicine, Autophagy/drug effects, Protein phosphatase methylesterase 1, Protein Phosphatase 2, Enzyme Inhibitors, PHOSPHORYLATION, Parkinson Disease/drug therapy, PubChem CID: 107970), DAP-KINASE, Mice, Knockout, Enzyme Inhibitors/pharmacology, 5284616) [Rapamycin (sirolimus, PubChem CID], Chemistry, Kinase, FTY-720 (fingolimod, Parkinson Disease, Alzheimer's disease, PP2A, 11198569) [KYP-2047 (PubChem CID], 3. Good health, Cell biology, Protein phosphatase 2 phosphatase activator, Serine protease, 317 Pharmacy, 030220 oncology & carcinogenesis, 446512) [Okadaic acid (PubChem CID], KYP-2047 (PubChem CID: 11198569), Rapamycin (sirolimus, Phosphorylation, Prolyl Oligopeptidases, Protein Phosphatase 2/metabolism, Knockout, Phosphatase, PubChem CID: 5284616), Cell Line, 03 medical and health sciences, SDG 3 - Good Health and Well-being, ENDOPEPTIDASE INHIBITOR, Autophagy, Humans, Animals, BECLIN 1, Neurodegeneration, Protein kinase A, 6436223) [Bafilomycin A1 (PubChem CID], PARKINSONS, Pharmacology, 135565635) [PP242 (PubChem CID], Activator (genetics), Prolyl Oligopeptidases/antagonists & inhibitors, Protein phosphatase 2, Okadaic acid (PubChem CID: 446512), Mice, Inbred C57BL, 030104 developmental biology, PP242 (PubChem CID: 135565635), HEK293 Cells, Bafilomycin A1 (PubChem CID: 6436223), Gene Deletion

  5. 5
  6. 6